Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence

By Zinner Norman R  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1559-1566

Informa Healthcare

Access to resources Recommend Favorite

Reboxetine: the first selective noradrenaline re-uptake inhibitor

By Kasper S.   Giamal N.E.   Hilger E.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 771-782

Informa Healthcare

Access to resources Recommend Favorite

WAY 100,635 enhances both the `antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex

By Millan M.J.   Brocco M.   Veiga S.   Cistarelli L.   Melon C.   Gobert A.  

European Journal of Pharmacology, Vol. 341, Iss. 2, 1998-01 ,pp. : 165-167

Elsevier

Access to resources Recommend Favorite

LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine 2A receptor antagonist: a comparison with the antidepressant, nefazodone

By Pullar I.A.   Carney S.L.   Colvin E.M.   Lucaites V.L.   Nelson D.L.   Wedley S.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite

Lack of adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine

By Nalepa I.   Manier D.H.   Gillespie D.D.   Rossby S.P.   Schmidt D.E.   Sulser F.  

European Neuropsychopharmacology, Vol. 8, Iss. 3, 1998-08 ,pp. : 227-232

Elsevier

Access to resources Recommend Favorite